MediSolution Ltd. Going Private Transaction Is Approved

  MediSolution Ltd. (TSX: MSH) ("MediSolution") and Brookfield Asset Management Inc. (TSX: BAM)(NYSE: BAM)(EURONEXT: BAMA) ("Brookfield") announced today that at a special meeting of shareholders of MediSolution held this morning, the amalgamation (the "Amalgamation") of MediSolution with an indirect wholly-owned subsidiary of Brookfield was approved by 99.28% of the total votes cast at the meeting and by 97.84% of the minority held shares cast at the meeting. MediSolution and Brookfield intend to complete the Amalgamation as soon as practicable.

Pursuant to the Amalgamation, each common share of MediSolution, other than those held by Brookfield and its subsidiaries, will be exchanged (by way of one redeemable preferred share of the amalgamated corporation) for C$0.30 in cash.

Upon completion of the Amalgamation, Brookfield will beneficially own all of the outstanding common shares of MediSolution.

The common shares are expected to be de-listed from the Toronto Stock Exchange within three business days of the Amalgamation becoming effective. MediSolution intends to apply to the applicable securities regulatory authorities in order to cease to be a reporting issuer under the applicable securities legislation as soon as practicable.

About MediSolution Ltd.

MediSolution (TSX: MSH), a Brookfield Asset Management company, is a leading information technology company, providing enterprise resource planning and specialized blood bank software, solutions and services to healthcare and service sector customers across North America. More than 300 healthcare, public and service sector organizations rely on MediSolution's systems to maximize their operational efficiencies, lower their costs and improve the delivery of services. The company's product portfolio is comprised of Financial Management software such as accounts receivable, budgeting and materials management, Business Intelligence solutions as well as Human Capital Management tools and services including human resources management, staff scheduling and payroll processing. The company also provides specialty hemovigilance solutions that improve patient safety, reduce waste and increase efficiency for blood transfusion services. For more information, please visit www.medisolution.com.

About Brookfield

Brookfield Asset Management Inc. is focused on property, power and infrastructure assets and has approximately US$80 billion of assets under management. Brookfield's common shares are listed on the New York and Toronto Stock Exchanges under the symbol BAM and on Euronext under the symbol BAMA. For more information, please visit www.brookfield.com.

Contacts: MediSolution Ltd. Paul Lepage President and Chief Executive Officer [phone] [e-mail] Brookfield Asset Management Inc. Denis Couture SVP, Investor Relations and Corporate and International Affairs [phone] [e-mail]